Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1997 Sep;226(3):248–260. doi: 10.1097/00000658-199709000-00004

Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes.

C J Yeo 1, J L Cameron 1, T A Sohn 1, K D Lillemoe 1, H A Pitt 1, M A Talamini 1, R H Hruban 1, S E Ord 1, P K Sauter 1, J Coleman 1, M L Zahurak 1, L B Grochow 1, R A Abrams 1
PMCID: PMC1191017  PMID: 9339931

Abstract

OBJECTIVE: The authors reviewed the pathology, complications, and outcomes in a consecutive group of 650 patients undergoing pancreaticoduodenectomy in the 1990s. SUMMARY BACKGROUND DATA: Pancreaticoduodenectomy has been used increasingly in recent years to resect a variety of malignant and benign diseases of the pancreas and periampullary region. METHODS: Between January 1990 and July 1996, inclusive, 650 patients underwent pancreaticoduodenal resection at The Johns Hopkins Hospital. Data were recorded prospectively on all patients. All pathology specimens were reviewed and categorized. Statistical analyses were performed using both univariate and multivariate models. RESULTS: The patients had a mean age of 63 +/- 12.8 years, with 54% male and 91% white. The number of resections per year rose from 60 in 1990 to 161 in 1995. Pathologic examination results showed pancreatic cancer (n = 282; 43%), ampullary cancer (n = 70; 11%), distal common bile duct cancer (n = 65; 10%), duodenal cancer (n = 26; 4%), chronic pancreatitis (n = 71; 11%), neuroendocrine tumor (n = 31; 5%), periampullary adenoma (n = 21; 3%), cystadenocarcinoma (n = 14; 2%), cystadenoma (n = 25; 4%), and other (n = 45; 7%). The surgical procedure involved pylorus preservation in 82%, partial pancreatectomy in 95%, and portal or superior mesenteric venous resection in 4%. Pancreatic-enteric reconstruction, when appropriate, was via pancreaticojejunostomy in 71% and pancreaticogastrostomy in 29%. The median intraoperative blood loss was 625 mL, median units of red cells transfused was zero, and the median operative time was 7 hours. During this period, 190 consecutive pancreaticoduodenectomies were performed without a mortality. Nine deaths occurred in-hospital or within 30 days of operation (1.4% operative mortality). The postoperative complication rate was 41%, with the most common complications being early delayed gastric emptying (19%), pancreatic fistula (14%), and wound infection (10%). Twenty-three patients required reoperation in the immediate postoperative period (3.5%), most commonly for bleeding, abscess, or dehiscence. The median postoperative length of stay was 13 days. A multivariate analysis of the 443 patients with periampullary adenocarcinoma indicated that the most powerful independent predictors favoring long-term survival included a pathologic diagnosis of duodenal adenocarcinoma, tumor diameter <3 cm, negative resection margins, absence of lymph node metastases, well-differentiated histology, and no reoperation. CONCLUSIONS: This single institution, high-volume experience indicates that pancreaticoduodenectomy can be performed safely for a variety of malignant and benign disorders of the pancreas and periampullary region. Overall survival is determined largely by the pathology within the resection specimen.

Full text

PDF
248

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison D. C., Bose K. K., Hruban R. H., Piantadosi S., Dooley W. C., Boitnott J. K., Cameron J. L. Pancreatic cancer cell DNA content correlates with long-term survival after pancreatoduodenectomy. Ann Surg. 1991 Dec;214(6):648–656. doi: 10.1097/00000658-199112000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bakkevold K. E., Arnesjø B., Dahl O., Kambestad B. Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater--results of a controlled, prospective, randomised multicentre study. Eur J Cancer. 1993;29A(5):698–703. doi: 10.1016/s0959-8049(05)80349-1. [DOI] [PubMed] [Google Scholar]
  3. Barens S. A., Lillemoe K. D., Kaufman H. S., Sauter P. K., Yeo C. J., Talamini M. A., Pitt H. A., Cameron J. L. Pancreaticoduodenectomy for benign disease. Am J Surg. 1996 Jan;171(1):131–135. doi: 10.1016/s0002-9610(99)80087-7. [DOI] [PubMed] [Google Scholar]
  4. Bosset J. F., Pavy J. J., Gillet M., Mantion G., Pelissier E., Schraub S. Conventional external irradiation alone as adjuvant treatment in resectable pancreatic cancer: results of a prospective study. Radiother Oncol. 1992 Jul;24(3):191–194. doi: 10.1016/0167-8140(92)90379-9. [DOI] [PubMed] [Google Scholar]
  5. Braasch J. W., Deziel D. J., Rossi R. L., Watkins E., Jr, Winter P. F. Pyloric and gastric preserving pancreatic resection. Experience with 87 patients. Ann Surg. 1986 Oct;204(4):411–418. doi: 10.1097/00000658-198610000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Böttger T. C., Störkel S., Wellek S., Stöckle M., Junginger T. Factors influencing survival after resection of pancreatic cancer. A DNA analysis and a histomorphologic study. Cancer. 1994 Jan 1;73(1):63–73. doi: 10.1002/1097-0142(19940101)73:1<63::aid-cncr2820730113>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  7. Cameron J. L., Pitt H. A., Yeo C. J., Lillemoe K. D., Kaufman H. S., Coleman J. One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann Surg. 1993 May;217(5):430–438. doi: 10.1097/00000658-199305010-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Carducci M. A., Abrams R. A., Yeo C. J., Hruban R. H., Zahurak M. L., Cameron J. L., Grochow L. B. Early evaluation of abdominal/hepatic irradiation and 5-fluorouracil/leucovorin infusion after pancreaticoduodenectomy. Int J Radiat Oncol Biol Phys. 1996 Apr 1;35(1):143–150. doi: 10.1016/s0360-3016(96)85023-1. [DOI] [PubMed] [Google Scholar]
  9. Crile G., Jr The advantages of bypass operations over radical pancreatoduodenectomy in the treatment of pancreatic carcinoma. Surg Gynecol Obstet. 1970 Jun;130(6):1049–1053. [PubMed] [Google Scholar]
  10. Crist D. W., Sitzmann J. V., Cameron J. L. Improved hospital morbidity, mortality, and survival after the Whipple procedure. Ann Surg. 1987 Sep;206(3):358–365. doi: 10.1097/00000658-198709000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cullen J. J., Sarr M. G., Ilstrup D. M. Pancreatic anastomotic leak after pancreaticoduodenectomy: incidence, significance, and management. Am J Surg. 1994 Oct;168(4):295–298. doi: 10.1016/s0002-9610(05)80151-5. [DOI] [PubMed] [Google Scholar]
  12. Fernández-del Castillo C., Rattner D. W., Warshaw A. L. Standards for pancreatic resection in the 1990s. Arch Surg. 1995 Mar;130(3):295–300. doi: 10.1001/archsurg.1995.01430030065013. [DOI] [PubMed] [Google Scholar]
  13. Geer R. J., Brennan M. F. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg. 1993 Jan;165(1):68–73. doi: 10.1016/s0002-9610(05)80406-4. [DOI] [PubMed] [Google Scholar]
  14. Gordon T. A., Burleyson G. P., Tielsch J. M., Cameron J. L. The effects of regionalization on cost and outcome for one general high-risk surgical procedure. Ann Surg. 1995 Jan;221(1):43–49. doi: 10.1097/00000658-199501000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Howard J. M. Pancreatico-duodenectomy: forty-one consecutive Whipple resections without an operative mortality. Ann Surg. 1968 Oct;168(4):629–640. doi: 10.1097/00000658-196810000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kalser M. H., Ellenberg S. S. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg. 1985 Aug;120(8):899–903. doi: 10.1001/archsurg.1985.01390320023003. [DOI] [PubMed] [Google Scholar]
  17. Lieberman M. D., Kilburn H., Lindsey M., Brennan M. F. Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy. Ann Surg. 1995 Nov;222(5):638–645. doi: 10.1097/00000658-199511000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lillemoe K. D., Cameron J. L., Yeo C. J., Sohn T. A., Nakeeb A., Sauter P. K., Hruban R. H., Abrams R. A., Pitt H. A. Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer? Ann Surg. 1996 Jun;223(6):718–728. doi: 10.1097/00000658-199606000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Martin R. F., Rossi R. L., Leslie K. A. Long-term results of pylorus-preserving pancreatoduodenectomy for chronic pancreatitis. Arch Surg. 1996 Mar;131(3):247–252. doi: 10.1001/archsurg.1996.01430150025004. [DOI] [PubMed] [Google Scholar]
  20. Miedema B. W., Sarr M. G., van Heerden J. A., Nagorney D. M., McIlrath D. C., Ilstrup D. Complications following pancreaticoduodenectomy. Current management. Arch Surg. 1992 Aug;127(8):945–950. doi: 10.1001/archsurg.1992.01420080079012. [DOI] [PubMed] [Google Scholar]
  21. Nakeeb A., Lillemoe K. D., Cameron J. L. The role of pancreaticoduodenectomy for locally recurrent or metastatic carcinoma to the periampullary region. J Am Coll Surg. 1995 Feb;180(2):188–192. [PubMed] [Google Scholar]
  22. Nakeeb A., Pitt H. A., Sohn T. A., Coleman J., Abrams R. A., Piantadosi S., Hruban R. H., Lillemoe K. D., Yeo C. J., Cameron J. L. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg. 1996 Oct;224(4):463–475. doi: 10.1097/00000658-199610000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Shapiro T. M. Adenocarcinoma of the pancreas: a statistical analysis of biliary bypass vs Whipple resection in good risk patients. Ann Surg. 1975 Dec;182(6):715–721. doi: 10.1097/00000658-197512000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Talamini M. A., Moesinger R. C., Pitt H. A., Sohn T. A., Hruban R. H., Lillemoe K. D., Yeo C. J., Cameron J. L. Adenocarcinoma of the ampulla of Vater. A 28-year experience. Ann Surg. 1997 May;225(5):590–600. doi: 10.1097/00000658-199705000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Traverso L. W., Kozarek R. A. The Whipple procedure for severe complications of chronic pancreatitis. Arch Surg. 1993 Sep;128(9):1047–1053. doi: 10.1007/978-3-642-77437-9_45. [DOI] [PubMed] [Google Scholar]
  26. Trede M., Schwall G., Saeger H. D. Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg. 1990 Apr;211(4):447–458. doi: 10.1097/00000658-199004000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Trede M., Schwall G. The complications of pancreatectomy. Ann Surg. 1988 Jan;207(1):39–47. doi: 10.1097/00000658-198801000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. WHIPPLE A. O. A reminiscence: pancreaticduodenectomy. Rev Surg. 1963 Jul-Aug;20:221–225. [PubMed] [Google Scholar]
  29. Whipple A. O., Parsons W. B., Mullins C. R. TREATMENT OF CARCINOMA OF THE AMPULLA OF VATER. Ann Surg. 1935 Oct;102(4):763–779. doi: 10.1097/00000658-193510000-00023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Yeo C. J., Abrams R. A., Grochow L. B., Sohn T. A., Ord S. E., Hruban R. H., Zahurak M. L., Dooley W. C., Coleman J., Sauter P. K. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann Surg. 1997 May;225(5):621–636. doi: 10.1097/00000658-199705000-00018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Yeo C. J., Barry M. K., Sauter P. K., Sostre S., Lillemoe K. D., Pitt H. A., Cameron J. L. Erythromycin accelerates gastric emptying after pancreaticoduodenectomy. A prospective, randomized, placebo-controlled trial. Ann Surg. 1993 Sep;218(3):229–238. doi: 10.1097/00000658-199309000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Yeo C. J., Cameron J. L. Alternative techniques for performing the Whipple operation. Adv Surg. 1996;30:293–310. [PubMed] [Google Scholar]
  33. Yeo C. J., Cameron J. L., Lillemoe K. D., Sitzmann J. V., Hruban R. H., Goodman S. N., Dooley W. C., Coleman J., Pitt H. A. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg. 1995 Jun;221(6):721–733. doi: 10.1097/00000658-199506000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Yeo C. J., Cameron J. L., Maher M. M., Sauter P. K., Zahurak M. L., Talamini M. A., Lillemoe K. D., Pitt H. A. A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Ann Surg. 1995 Oct;222(4):580–592. doi: 10.1097/00000658-199510000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Yeo C. J. Management of complications following pancreaticoduodenectomy. Surg Clin North Am. 1995 Oct;75(5):913–924. doi: 10.1016/s0039-6109(16)46736-8. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES